## Core Concept
Metyrapone is a medication used in the diagnosis of adrenal insufficiency and in research related to the regulation of cortisol production. It acts by inhibiting a key enzyme in the biosynthesis of cortisol from cholesterol in the adrenal cortex.

## Why the Correct Answer is Right
Metyrapone specifically inhibits **11β-hydroxylase**, an enzyme crucial for the conversion of 11-deoxycortisol to cortisol in the adrenal cortex. By blocking this enzyme, metyrapone effectively reduces cortisol production. This mechanism is significant because it leads to an accumulation of 11-deoxycortisol, which can be measured to assess the integrity of the hypothalamic-pituitary-adrenal (HPA) axis.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because metyrapone does not primarily inhibit cholesterol side-chain cleavage enzyme (P450scc), which is involved in an earlier step of steroidogenesis, converting cholesterol to pregnenolone.
- **Option B:** This option is incorrect as metyrapone's action is not primarily on 17α-hydroxylase, an enzyme involved in converting pregnenolone to 17-hydroxypregnenolone.
- **Option D:** This option is incorrect because metyrapone does not primarily inhibit 21-hydroxylase, an enzyme involved in converting 17-hydroxyprogesterone to 11-deoxycorticosterone.

## Clinical Pearl / High-Yield Fact
A key clinical use of metyrapone is in the **metyrapone test**, which can help diagnose adrenal insufficiency and assess the function of the HPA axis. Metyrapone's ability to decrease cortisol production can also make it useful in managing Cushing's syndrome, although its use is limited by side effects.

## Correct Answer: C. 11β-hydroxylase.